Abstract
Academic researchers tread a fine line when they criticise the pharmaceutical industry, which is one of the major funders of clinical trials. Prof Sylvio Garattini is perhaps one of the few respected enough to challenge the industry, having been director of the Mario Negri Institute of Pharmacological Research in Milan for over 30 years. Speaking at the Italian Institute of Culture in London earlier this month, he called for a new European agency to be set up to coordinate and support pharmaceutical research that is not profit-oriented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
